Scholars Central

Conference abstractPublished 1 Dec 2016

RA improves cognitive function of Alzheimer′s disease mouse model through inhibition of BACE1 expression and neuroinflammation

Authors: Gun Young Jung

Sungkyunkwan University School of Pharmacy, Republic of Korea

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

AlzheimerâÂ?Â?s disease (AD) is the most common dementing illness, and the peptide amyloid-Ã?² (AÃ?²) has a chief function in the pathogenesis of AD. Sequential proteolysis of amyloid precursor protein (APP) by BACE1 and Ã?³-secretase produces AÃ?² which drives cerebral neuroinflammation. Recent findings have provided insight into a newly discovered inflammatory mechanism that contributes to the pathogenesis of Alzheimer's disease mediated by multi-protein complexes called NLRP inflammasomes. In the present study, we orally administered the brain penetrant, natural compound isolated from compound RA to the transgenic APP/PS1 (bearing mutant human APP and presenilin-1 transgenes) and 3xTg-AD (bearing mutant human APP, presenilin-1, and tau transgenes) mice models of AlzheimerâÂ?Â?s disease. Oral treatment of natural compound reversed transgene-associated behavioral deficits, but did not alter wild-type mouse behaviors. Furthermore, brain AÃ?² depositions as well as abundance of various AÃ?² species were decreased in natural compound-treated AD mice. These effects occurred with decreased cleavage of Ã?²-carboxy-terminal APP fragment, reduced BACE1 expression, attenuated neuroinflammation, and reduced expression of NLRP inflammasome proteins. As in vitro validation, we treated neuronal and microglial cells with this compound and found that the levels of NLRP inflammasome proteins, AÃ?² production, BACE1 expression, and oxidative stress were significantly decreased. Collectively, our findings reveal this compound as a potential therapeutic modality for targeting AÃ?² production and AÃ?²-induced NLRP inflammasomes.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Alzheimers Disease & Parkinsonism.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Alzheimers Disease & Parkinsonism
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Gun Young Jung”